For example, breast cancer cells are shown to respond to higher circulating levels of certain pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6 by increasing the expression of P450 aromatase [29,46]. This evidence concerns the gene IL1B and breast carcinoma.